Yi Rui Artificial Intelligence Research Center of Zhejiang University (hereinafter referred to as "Zhejiang University Yi Rui") became the technology platform contractor of the fund.
In order to promote the above-mentioned work to be carried out efficiently, the Chinese Medical Association has set up a special fund and reward management committee, with Han Demin, academician of China Academy of Engineering and president of the Chinese Medical Association, as the director of the management committee, and Dong Erdan, executive deputy director of the Medical Science Department of the National Natural Science Foundation of China, as the executive deputy director. On the same day, academicians Zhan, Martin, Xu Jianguo of China Academy of Engineering, as well as more than 200 experts such as chairmen and secretaries-general of various branches of Chinese Medical Association witnessed the establishment of the above-mentioned special project.
Huaxia Medical Science and Technology Award is a national award approved by the Ministry of Science and Technology and the National Science and Technology Awards Office, established and sponsored by the China Medical Promotion Association. The Huaxia Medical Science and Technology Awards Committee is chaired and vice-chaired by 68 academicians of the two academies. Huaxia Medical Science and Technology Award has been successfully held for 7 sessions, with 388 award-winning projects. A number of award-winning projects have won the highest national science and technology awards, and in recent years, they have been directly recommended by the highest national science and technology awards known as the "China Prize in Medicine". The medical science and technology innovation project led by Liao and Academician of China Academy of Engineering won this honor.
The report of the 19th National Congress of the Communist Party of China pointed out that it is necessary to improve the national health policy, provide all-round and full-cycle health services for the people, and vigorously promote the implementation of the "healthy China" strategy. 2065438+March 2007, "artificial intelligence" was written into the work report of the State Council government for the first time and rose to the national strategy. In order to respond to this strategy and deepen the integration of new technology and medical care, Huaxia Medical Artificial Intelligence Special Fund and Special Award came into being.
Academician Han Demin said at the meeting that medical artificial intelligence is the second half of Internet medical care and the key work direction of Chinese Medical Association 20 18.
Huaxia Medical Artificial Intelligence Foundation focuses on supporting the application of artificial intelligence technology in the fields of chronic diseases, specialized diseases, frontier medical exploration, etc. According to major, key and general projects, special grants with the amount of 5 million yuan, 3 million yuan and 1 10,000 yuan-1.5,000 yuan are respectively carried out to promote the transformation and landing of China's leading medical artificial intelligence achievements.
Professor Wu Jian, a medical artificial intelligence expert from Zhejiang University, is the director of the center.
As the first open medical artificial intelligence platform in China, Yi Rui of Zhejiang University will focus on the screening of funded projects and provide technical and landing support for the transformation of project results. Zhejiang University, led by Wu, academician of China Academy of Sciences and president of Zhejiang University, is headed by a well-known medical artificial intelligence expert and professor of Zhejiang University. Open cooperation with experts from major medical institutions, disciplines and industries, build a medical artificial intelligence service platform and cultivate third-party medical artificial intelligence service enterprises around the common key technologies of medical artificial intelligence such as clinical big data, imaging and genomics.
Since its establishment in March, 20 17, Yi Rui Artificial Intelligence Research Center of Zhejiang University has made important breakthroughs in the research and development of more than ten intelligent applications such as diabetic retinopathy, pulmonary nodules, general practice, bone age and cervical cancer. Among them, the accuracy and sensitivity of cervical cancer screening can rival that of doctors; In most data sets, the specificity and sensitivity of AI diabetic retinopathy grade 2 are 99% and 95%.